A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2017-10-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.1716009114PMID 29087350PMCID PMC5699095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas

  2016cited by this paper
• Advances in sarcoma diagnostics and treatment

  2016cited by this paper
• Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function.

  2015cited by this paper
• Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.

  2015cited by this paper
• Cytokinetic Failure-induced Tetraploidy Develops into Aneuploidy, Triggering Skin Aging in Phosphovimentin-deficient Mice*

  2015cited by this paper
• Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding

  2015cited by this paper
• A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in Cancer.

  2015cited by this paper
• Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ.

  2014cited by this paper
• [WHO classification of tumours of soft tissue and bone 2013: the main changes compared to the 3rd edition].

  2014influential reference
• FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.

  2013cited by this paper
• Growth Arrest by the Antitumor Steroidal Lactone Withaferin A in Human Breast Cancer Cells Is Associated with Down-regulation and Covalent Binding at Cysteine 303 of β-Tubulin*

  2013cited by this paper
• Withaferin A Alters Intermediate Filament Organization, Cell Shape and Behavior

  2012cited by this paper
• Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression

  2011cited by this paper
• Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells

  2011cited by this paper
• A Perspective on Cancer Cell Metastasis

  2011cited by this paper
• Vimentin in cancer and its potential as a molecular target for cancer therapy

  2011influential reference
• Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies

  2010cited by this paper
• Withaferin A Targets Intermediate Filaments Glial Fibrillary Acidic Protein and Vimentin in a Model of Retinal Gliosis*

  2010cited by this paper
• Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

  2010cited by this paper
• Antitumor activity of an allosteric inhibitor of centromere-associated protein-E

  2010cited by this paper
• High Throughput Screening

  2009cited by this paper
• Identification of selective inhibitors of cancer stem cells by high-throughput screening.

  2009cited by this paper
• Vimentin coil 1A-A molecular switch involved in the initiation of filament elongation.

  2009cited by this paper
• BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells

  2007cited by this paper
• Novel functions of vimentin in cell adhesion, migration, and signaling.

  2007influential reference
• Intermediate filaments: from cell architecture to nanomechanics

  2007cited by this paper
• Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

  2007cited by this paper
• The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin.

  2007influential reference
• In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

  2007cited by this paper
• Regulatory mechanisms and functions of intermediate filaments: A study using site‐ and phosphorylation state‐specific antibodies

  2006influential reference
• Phosphorylation by Cdk1 induces Plk1-mediated vimentin phosphorylation during mitosis

  2005cited by this paper
• The Concept of Synthetic Lethality in the Context of Anticancer Therapy

  2005cited by this paper
• Selective and irreversible cell cycle inhibition by diphenyleneiodonium

  2005cited by this paper
• In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

  2003cited by this paper
• Aurora-B Regulates the Cleavage Furrow-specific Vimentin Phosphorylation in the Cytokinetic Process*

  2003cited by this paper
• Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells.

  2003cited by this paper
• Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

  2001cited by this paper
• Protein kinases required for segregation of vimentin filaments in mitotic process

  2001cited by this paper
• Intermediate filaments in motion: observations of intermediate filaments in cells using green fluorescent protein-vimentin.

  1999cited by this paper
• Rapid Movements of Vimentin on Microtubule Tracks: Kinesin-dependent Assembly of Intermediate Filament Networks

  1998cited by this paper
• Phosphorylation of Vimentin by Rho-associated Kinase at a Unique Amino-terminal Site That Is Specifically Phosphorylated during Cytokinesis*

  1998cited by this paper
• Intermediate filaments: structure, dynamics, function, and disease.

  1994cited by this paper
• Regulated docking of nuclear membrane vesicles to vimentin filaments during mitosis

  1993cited by this paper
• Intermediate

  1980cited by this paper
• Intermediate filaments anchor the nuclei in nuclear monolayers of cultured human fibroblasts

  1978cited by this paper

• Extracellular vimentin amplifies inflammation: Perspectives for immune injury and therapeutics for periodontitis

  2025cites this paper
• L-Sarcolysine Reduced the Mobility of Human Glioblastoma Cells, with Potential Involvement of Vimentin

  2025cites this paper
• Intermediate filaments and their associated molecules

  2024cites this paper
• Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review.

  2024cites this paper
• Photoaffinity labelling with small molecules

  2024cites this paper
• Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer

  2024cites this paper
• A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity

  2024cites this paper
• The Cancer Chimera: Impact of Vimentin and Cytokeratin Co-Expression in Hybrid Epithelial/Mesenchymal Cancer Cells on Tumor Plasticity and Metastasis

  2024cites this paper
• Atractylodinol prevents pulmonary fibrosis through inhibiting TGF-β receptor 1 recycling by stabilizing vimentin.

  2023cites this paper
• Vimentin-targeted radiopeptide 99mTc-HYNIC-(tricine/EDDA)-VNTANST: a promising drug for pulmonary fibrosis imaging

  2023cites this paper
• Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance

  2023cites this paper
• Exploring the Potential of Metal‐Based Candidate Drugs as Modulators of the Cytoskeleton

  2023cites this paper
• Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomas

  2023influential citation
• AKT from dental epithelium to papilla promotes odontoblast differentiation.

  2023cites this paper
• Linker optimization and activity validation of a cell surface vimentin targeted homo-dimeric peptoid antagonist for lung cancer stem cells.

  2023cites this paper
• Synthesis and biological evaluation of novel FiVe1 derivatives as potent and selective agents for the treatment of mesenchymal cancers.

  2022cites this paper
• Withaferin A, a polyfunctional pharmacophore that includes covalent engagement of IPO5, is an inhibitor of influenza A replication.

  2022cites this paper
• Cytokeratins 5 and 17 maintain an aggressive epithelial state in basal-like breast cancer.

  2022cites this paper
• Can Butein be a Future Candidate for the Treatment of Advance Metastatic Thyroid Cancer?

  2022cites this paper
• Unbiased peptoid cell screen identifies a peptoid targeting newly appeared cell surface vimentin on tumor transformed early lung cancer cells.

  2022cites this paper
• Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis

  2022cites this paper
• ALD-R491 regulates vimentin filament stability and solubility, cell contractile force, cell migration speed and directionality

  2022cites this paper
• Modulation of gene expression by YTH domain family (YTHDF) proteins in human physiology and pathology

  2022cites this paper
• Abberant Immunohistochemical Expression of OCT3/4 and EMT Related Markers, Vimentin and E-cadherin, is Correlated with Adverse Histopathological Features in Colorectal Adenocarcinoma.

  2022cites this paper
• Mechanisms of cancer metastasis.

  2022cites this paper
• Butein exhibits anti-tumor effect through intrinsic pathway of apoptosis, vimentin proteolysis, and inhibition of cancer stem cell population in the human papillary thyroid cancer cell line.

  2021cites this paper
• YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway

  2021cites this paper
• A short ORF-encoded transcriptional regulator

  2021cites this paper
• Chemoproteomic-enabled phenotypic screening.

  2021cites this paper
• Insulin-Like Growth Factor Binding Protein-3 Exerts Its Anti-Metastatic Effect in Aerodigestive Tract Cancers by Disrupting the Protein Stability of Vimentin

  2021cites this paper
• Platinum(II) N-heterocyclic carbene complexes arrest metastatic tumor growth

  2021cites this paper
• Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis

  2021cites this paper
• Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway.

  2021cites this paper
• Molecular Insight into the Regulation of Vimentin by Cysteine Modifications and Zinc Binding

  2021cites this paper
• A Small Vimentin-Binding Molecule Blocks Cancer Exosome Release and Reduces Cancer Cell Mobility

  2021cites this paper
• Quercetin induces proteolysis of mesenchymal marker vimentin through activation of caspase-3, and decreases cancer stem cell population in human papillary thyroid cancer cell line.

  2021cites this paper
• HBV HBx-Downregulated lncRNA LINC01010 Attenuates Cell Proliferation by Interacting with Vimentin

  2021cites this paper
• A chemical tool for blue light-inducible proximity photo-crosslinking in live cells

  2021cites this paper
• Vimentin and cytokeratin: good alone, bad together.

  2021cites this paper
• Susceptibility of cytoskeletal-associated proteins for tumor progression

  2021cites this paper
• multiSLIDE is a web server for exploring connected elements of biological pathways in multi-omics data

  2021cites this paper
• Role of platelets and breast cancer stem cells in metastasis

  2020cites this paper
• From structural resilience to cell specification — Intermediate filaments as regulators of cell fate

  2020cites this paper
• FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer

  2020cites this paper
• Recent insight into intermediate filament structure.

  2020cites this paper
• Loss of ARID1A Promotes Epithelial–Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress

  2020cites this paper
• Vimentin as a target for the treatment of COVID-19

  2020cites this paper
• Relating the composition and interface interactions in the hard corona of gold nanoparticles to the induced response mechanisms in living cells.

  2020cites this paper
• Type III intermediate filaments as targets and effectors of electrophiles and oxidants

  2020cites this paper
• Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections

  2020cites this paper
• Influenza-induced activation of recruited alveolar macrophages during the early inflammatory phase drives lung injury and lethality

  2020cites this paper
• FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer

  2020cites this paper
• Vimentin is required for tumor progression and metastasis in a mouse model of non–small cell lung cancer

  2020cites this paper
• Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug Sensitivity

  2020influential citation
• FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer

  2020cites this paper
• Vimentin Intermediate Filaments as Potential Target for Cancer Treatment

  2020cites this paper
• Intermediate Filaments as Potential Target for Cancer 2 Treatment

  2019cites this paper
• multiSLIDE: a web server for exploring connected elements of biological pathways in multi-omics data

  2019cites this paper
• Mitotic Catastrophe Causes Podocyte Loss in the Urine of Human Diabetics.

  2019cites this paper
• Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products.

  2019cites this paper
• Intermediate filaments and IF-associated proteins: from cell architecture to cell proliferation

  2019cites this paper
• RETRACTED: Regulation of Long Non-Coding RNA-Dreh Involved in Proliferation and Migration of Hepatic Progenitor Cells during Liver Regeneration in Rats

  2019cites this paper
• The Expression of E-Cadherin and Vimentin in Non-Small-Cell Lung Cancer and Their Correlation with Epithelial-Mesenchymal Transition (EMT)

  2018cites this paper
• Vasculogenic mimicry and expression of slug and vimentin correlate with metastasis and prognosis in non-small cell lung cancer.

  2018cites this paper
• Vimentin Diversity in Health and Disease

  2018cites this paper
• DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer

  2018cites this paper
• Bioinspired Conical Micropattern Modulates Cell Behaviors.

  2018cites this paper